Tislelizumab Plus Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy for Elderly Patients with Inoperable Locally Advanced Esophageal Squamous Cell Carcinoma: a Multicenter, Randomized, Parallel-Controlled, Phase II Clinical Trial
BMC Cancer（2025）
关键词
Concurrent chemoradiotherapy,Immunotherapy,Locally advanced esophageal squamous cell carcinoma,Older patients,Tislelizumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要